Back
Theriva Biologics Stock Price Chart
Sponsored
TOVX
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
TOVX
Theriva Biologics
Last Price:
$1.71
Seasonality Move:
27.37%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight selling pressure.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.26 | Buy |
20-day SMA: | 1.28 | Buy |
50-day SMA: | 1.44 | Buy |
200-day SMA: | 5.52 | Sell |
8-day EMA: | 1.33 | Buy |
20-day EMA: | 1.31 | Buy |
50-day EMA: | 1.64 | Buy |
200-day EMA: | 5.19 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 67.95 | Buy |
Chaikin Money Flow: | -336796 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.16 - 1.4) | Buy |
Bollinger Bands (100): | (1.06 - 3.82) | Sell |
Theriva Biologics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.76 while TOVX 8-day simple moving average is 1.26, which is a Buy signal.
-
The stock price of TOVX is 1.76 while Theriva Biologics 20-day SMA is 1.28, which makes it a Buy.
-
Theriva Biologics 50-day simple moving average is 1.44 while TOVX share price is 1.76, making it a Buy technically.
-
TOVX stock price is 1.76 and Theriva Biologics 200-day simple moving average is 5.52, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Buy
56
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a BuyThe current Theriva Biologics [TOVX] share price is $1.76. The Score for TOVX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Theriva Biologics Stock Info
Market Cap:
4.9M
Price in USD:
1.76
Share Volume:
6.8M
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
1.14
Buy
56
Theriva Biologics (TOVX)
is a Buy
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?The Theriva Biologics stock price is 1.76 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is not overvalued.
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.76 while TOVX 8-day exponential moving average is 1.33, which is a Buy signal.
-
The stock price of TOVX is 1.76 while Theriva Biologics 20-day EMA is 1.31, which makes it a Buy.
-
Theriva Biologics 50-day exponential moving average is 1.64 while TOVX share price is 1.76, making it a Buy technically.
-
TOVX stock price is 1.76 and Theriva Biologics 200-day simple moving average is 5.19, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Theriva Biologics is a Sell
-
Theriva Biologics Relative Strength Index (RSI) is 67.95, which suggest Theriva Biologics is overbought
-
The Bollinger Bands (25) for Theriva Biologics is (1.16 - 1.4), which suggest Theriva Biologics is a Sell
-
The Bollinger Bands (100) for Theriva Biologics is (1.06 - 3.82), which suggest Theriva Biologics is a Sell
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.